Literature DB >> 18426825

Variations in the uncoupling protein-3 gene are associated with specific obesity phenotypes.

Annet F M van Abeelen1, Mariken de Krom, Judith Hendriks, Diederick E Grobbee, Roger A H Adan, Yvonne T van der Schouw.   

Abstract

OBJECTIVE: Uncoupling protein 3 (UCP-3) uncouples oxidative metabolism from ATP synthesis, resulting in the production of heat instead of energy storage. Single nucleotide polymorphisms (SNPs) in UCP-3 might result in a reduced function or expression of UCP-3 and therefore lead to an increased capacity to store energy as fat.
DESIGN: We conducted a population-based, cross-sectional single-center study among 400 Dutch men between 40 and 80 years.
METHODS: Seven SNPs in the UCP-3 gene were genotyped by means of an allele-specific real-time TaqMan PCR. Linear regression analyses were performed to examine the independent effects of these SNPs on obesity phenotypes.
RESULTS: We found a significant association between homozygosity for the minor allele of rs647126, rs1685356, and rs2075577 and an increase in body mass index (BMI; P=0.033, P=0.016, and P=0.019 respectively). Heterozygosity for rs1685354 was associated with a significant decrease in visceral fat mass (P=0.030).
CONCLUSIONS: Our results suggest that genetic variations in the UCP-3 gene are associated with an increase in BMI. A plausible mechanism by which these SNPs lead to an increase in BMI is that due to these SNPs, the UCP-3 activity might be decreased. As a result, uncoupling activity may also decrease, which will lead to an increase in body weight and BMI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426825     DOI: 10.1530/EJE-07-0834

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  7 in total

1.  UCP3 polymorphisms, hand grip performance and survival at old age: association analysis in two Danish middle aged and elderly cohorts.

Authors:  Serena Dato; Mette Soerensen; Alberto Montesanto; Vincenzo Lagani; Giuseppe Passarino; Kaare Christensen; Lene Christiansen
Journal:  Mech Ageing Dev       Date:  2012-06-26       Impact factor: 5.432

2.  Association of UCP-3 rs1626521 with obesity and stomach functions in humans.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Maria I Vazquez-Roque; Johanna Iturrino; Ian R Lanza; K Sreekumaran Nair; Duane Burton; Jessica O'Neill; Deborah Eckert; Paula Carlson; Adrian Vella; Alan R Zinsmeister
Journal:  Obesity (Silver Spring)       Date:  2015-03-07       Impact factor: 5.002

Review 3.  Mitochondrial-nuclear epistasis: implications for human aging and longevity.

Authors:  Gregory J Tranah
Journal:  Ageing Res Rev       Date:  2010-06-25       Impact factor: 10.895

4.  A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity.

Authors:  Athanasios Papathanasopoulos; Michael Camilleri; Paula J Carlson; Adrian Vella; Sara J Linker Nord; Duane D Burton; Suwebatu T Odunsi; Alan R Zinsmeister
Journal:  Obesity (Silver Spring)       Date:  2009-10-29       Impact factor: 5.002

Review 5.  Endocrine disrupters as obesogens.

Authors:  Felix Grün; Bruce Blumberg
Journal:  Mol Cell Endocrinol       Date:  2009-03-09       Impact factor: 4.102

6.  UCP2 and UCP3 variants and gene-environment interaction associated with prediabetes and T2DM in a rural population: a case control study in China.

Authors:  Meifang Su; Xiaoying Chen; Yue Chen; Congyun Wang; Songtao Li; Xuhua Ying; Tian Xiao; Na Wang; Qingwu Jiang; Chaowei Fu
Journal:  BMC Med Genet       Date:  2018-03-12       Impact factor: 2.103

7.  Variation in the UCP2 and UCP3 genes associates with abdominal obesity and serum lipids: the Finnish Diabetes Prevention Study.

Authors:  Titta Salopuro; Leena Pulkkinen; Jaana Lindström; Marjukka Kolehmainen; Anna-Maija Tolppanen; Johan G Eriksson; Timo T Valle; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Jaakko Tuomilehto; Markku Laakso; Matti Uusitupa
Journal:  BMC Med Genet       Date:  2009-09-21       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.